Neuryte develops EEG-based BCIs targeting paralysed patients and motor-control disorders, with embedded signal processing that reduces data transmission overhead. The founding team trained at UTS's Neurotech Lab and holds patents on novel electrode arrays. Early clinical partnerships are under way with major Australian rehabilitation centres.